Dementia Support Line
Alzheimer's Society pay tribute to Professor David Allsop
Alzheimer’s Society was saddened to hear of the recent death of Professor David Allsop on 8 March 2021.
A pioneer in the world of dementia research
Alzheimer’s Society is proud to have supported David through our funding programme in his research focusing on the pathological consequences of misfolded proteins in Alzheimer’s and Parkinson’s disease – most significantly leading the way with his research into the link between amyloid plaque formations in the brain and Alzheimer’s disease.
David was a long-term supporter of Alzheimer’s Society’s Research Programme; in particular, through his role as a member of our Research Strategy Council (RSC) from 2013 to 2016.
As a member of the RSC; David provided essential guidance, knowledge and advice, supporting Alzheimer’s Society in shaping their Research Programme to allow them to offer relevant and widespread opportunities and support to researchers at all stages of their careers.
Recognition from his peers
Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society said:
'David’s contribution to the field was felt all across the dementia research community, including charities such as Alzheimer’s Society. We were privileged to have been supported and guided by David over many years.'
'His passion and knowledge are still felt here at the Society.’
David's commitment to Alzheimer’s Society’s mission and values was evident to all; as Professor Carol Brayne (Co-Chair, RSC) explained:
'[David] was very committed… to the very real value of the way in which Alzheimer’s Society has brought patients, families and public alongside the research, and also his own contributions to the work of the RSC to shape and support all types of research.
'From his ground-breaking research to the encouragement and support, he gave to inspiring dementia researchers; David’s legacy will continue to make a difference for people affected by dementia for years to come.'
Professor Nick Fox, fellow RSC member, summarised David’s personal and professional contribution perfectly when he said:
'David was a generous and thoughtful member of the Society’s Research Strategy Council – always straightforward and a pleasure to work with – as well as being a very highly respected scientist who made major contributions to our understanding of amyloid and Alzheimer’s disease.'
